ClinicalTrials.Veeva

Menu

Gastroesophageal Reflux Disease Prospective Registry (GERD)

Baylor Scott and White Health (BSWH) logo

Baylor Scott and White Health (BSWH)

Status

Terminated

Conditions

GERD

Treatments

Other: Diagnosed with GERD

Study type

Observational

Funder types

Other

Identifiers

NCT02479438
014-008

Details and patient eligibility

About

The purpose of this registry is to evaluate information to determine which operations and treatments for gastroesophageal reflux disease or similar diseases of the stomach, esophagus or digestive tract are providing the most benefit including the long-term effects of treatment (or no treatment) and the progression of the disease over time.

Full description

All patients in this registry will have a diagnosis of gastroesophageal reflux disease or a similar disease of the stomach, esophagus or digestive tract. Each patient undergoing anti-reflux surgery will be asked to participate in the registry to gather preoperative, intraoperative and postoperative outcomes. The data collected from the registry will be used to assess the outcome of various treatments, both standard and new: some specific areas of interest include the long-term effects of treatment (or no treatment), the progression of the disease over time, and the overall length of survival of the patient.

Enrollment

744 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Any patient undergoing anti-reflux surgery

Exclusion criteria

  • None

Trial design

744 participants in 1 patient group

Diagnosed with GERD
Description:
Collect data on GERD patients
Treatment:
Other: Diagnosed with GERD

Trial contacts and locations

1

Loading...

Central trial contact

Christine Sanchez, MA; Tammy Fisher, RN

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems